Health
ColCORONA: Colchicine Reduces Complications in Outpatient COVID-19 – Medscape
The primary endpoint was not significant in the overall population, but in those with PCR-confirmed COVID, treatment reduced hospitalization, need for ventilation,…
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center.
The oral, anti-inflammatory drug colchicine can prevent complications and hospitalizations in nonhospitalized patients newly diagnosed with COVID-19, according to a press release from the ColCORONA trial investigators.
After 1 month of therapy, there was a 21% risk reduction in the primary composite endpoint of death or hospitalizations that missed statistical significance, compared with placebo…
-
General18 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News23 hours agoSouth-west Queensland highway closed after truck carrying oxygen cylinders catches fire
-
Noosa News18 hours agoWoman airlifted to Brisbane hospital after big cat mauling at south-east Queensland zoo near Toowoomba
-
Noosa News18 hours agoUnvaccinated horse dies from Hendra virus as Queensland records first case in three years